CeraVe Developed with Dermatologists BHA Exfoliating Toner Acne Treatment
- Product NDC
- 82046-291
- 11-digit product format
- 820460291
- Labeler code
- 82046
- Product ID
- 82046-291_5230f29c-9adc-8f5b-e063-6394a90af697
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Salicylic acid
- Dosage form
- LIQUID
- Route
- TOPICAL
- Labeler
- L'Oreal USA Products Inc
- Application
- M006
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2026-05-19
- Substance
- SALICYLIC ACID
- Active strength
- 20 mg/mL
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- CeraVe Developed with Dermatologists BHA Exfoliating Toner Acne Treatment
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| SALICYLIC ACID | 20 mg/mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | O414PZ4LPZ |
| Rxcui | 251577 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 82046-291-01 | CeraVe Developed with Dermatologists BHA Exfoliating Toner Acne Treatment | 237 mL in 1 BOTTLE | LIQUID | 237 | | 1 |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 82046-291-01 | 82046029101 | 237 mL in 1 BOTTLE (82046-291-01) | 237 ml | 2026-05-19 | No | No | Historical |